Literature DB >> 21340462

Various morphometric measurements of cancer extent on needle prostatic biopsies: which is predictive of pathologic stage and biochemical recurrence following radical prostatectomy?

Maisa M Q Quintal1, Luciana R Meirelles, Leandro L L Freitas, Luis A Magna, Ubirajara Ferreira, Athanase Billis.   

Abstract

OBJECTIVES: To find whether any particular method of measuring cancer extent on needle prostatic biopsies is superior to others in predicting pathological stage >T2 and biochemical recurrence following radical prostatectomy.
MATERIALS AND METHODS: The study was based on 168 extended biopsies and the correspondent step-sectioned surgical specimens. Tumor extent was evaluated as: (1) number and percentage of cores with carcinoma; (2) total length and percentage of cancer in mm in all cores; and (3) the greatest length and percentage of cancer in a single core.
RESULTS: All measurements significantly predicted stage >pT2 using logistic regression. With the exception of the greatest length and percentage of cancer in a single core, all other methods were also associated with a higher risk for biochemical recurrence (Cox method). Percentage of length of carcinoma in all cores was significantly and consistently stronger than other measures in all comparisons and combined to preoperative PSA and Gleason grade in multivariate analysis gained prediction for pathologic stage >T2 and was independent of risk of biochemical recurrence.
CONCLUSIONS: Percentage of total length of carcinoma in mm in all cores of a needle biopsy had the strongest predictive positive value for stage >pT2 and risk for biochemical recurrence following radical prostatectomy. Combined with preoperative PSA and Gleason grade on biopsy may improve the predictive value for stage >pT2.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21340462     DOI: 10.1007/s11255-011-9901-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  31 in total

1.  Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.

Authors:  Alberto Briganti; Felix K-H Chun; Georg C Hutterer; Andrea Gallina; Shahrokh F Shariat; Andrea Salonia; Vincenzo Scattoni; Luc Valiquette; Francesco Montorsi; Patrizio Rigatti; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2007-03-06       Impact factor: 20.096

2.  The importance of the quantification of the extent of cancer in prostatic biopsies in prediction of biochemical recurrence: a global perspective.

Authors:  Umberto Capitanio; Alberto Briganti; Shahrokh F Shariat; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2008-07-21       Impact factor: 20.096

3.  The combination of millimetres of cancer and Gleason index in core biopsy is a predictor of extraprostatic disease.

Authors:  J I López; C Etxezarraga
Journal:  Histopathology       Date:  2006-05       Impact factor: 5.087

4.  Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma.

Authors:  M A Rubin; N Bassily; M Sanda; J Montie; M S Strawderman; K Wojno
Journal:  Am J Surg Pathol       Date:  2000-02       Impact factor: 6.394

5.  Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score.

Authors:  Stephen J Freedland; George S Csathy; Frederick Dorey; William J Aronson
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

6.  Percent of cancer in the biopsy set predicts pathological findings after prostatectomy.

Authors:  David J Grossklaus; Christopher S Coffey; Scott B Shappell; Gregory S Jack; Sam S Chang; Michael S Cookson
Journal:  J Urol       Date:  2002-05       Impact factor: 7.450

7.  Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies.

Authors:  Y Goto; M Ohori; A Arakawa; M W Kattan; T M Wheeler; P T Scardino
Journal:  J Urol       Date:  1996-09       Impact factor: 7.450

8.  Preoperative determination of prostate cancer tumor volume: analysis through biopsy fragments.

Authors:  Alberto A Antunes; Miguel Srougi; Marcos F Dall'Oglio; Alexandre Crippa; Adriano J Nesrallah; Luciano J Nesrallah; Katia R Leite
Journal:  Int Braz J Urol       Date:  2007 Jul-Aug       Impact factor: 1.541

9.  Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed?

Authors:  P Pepe; F Fraggetta; A Galia; G Grasso; S Piccolo; F Aragona
Journal:  Urology       Date:  2008-12       Impact factor: 2.649

10.  Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen.

Authors:  Stephen J Freedland; Martha K Terris; George S Csathy; Christopher J Kane; Christopher L Amling; Joseph C Presti; Frederick Dorey; William J Aronson
Journal:  J Urol       Date:  2004-06       Impact factor: 7.450

View more
  7 in total

1.  [Prostate biopsy - an unending story].

Authors:  G Mikuz
Journal:  Pathologe       Date:  2012-03       Impact factor: 1.011

2.  Comparison of two commonly used methods in measurement of cancer volume in prostate biopsy.

Authors:  Viharkumar Patel; Samuel Hubbard; Wei Huang
Journal:  Int J Clin Exp Pathol       Date:  2020-04-01

3.  Cancer core length from targeted biopsy: an index of prostate cancer volume and pathological stage.

Authors:  Demetrios N Simopoulos; Anthony E Sisk; Alan Priester; Ely R Felker; Lorna Kwan; Merdie K Delfin; Robert E Reiter; Leonard S Marks
Journal:  BJU Int       Date:  2019-02-24       Impact factor: 5.969

4.  Prostate cancer volume estimations based on transrectal ultrasonography-guided biopsy in order to predict clinically significant prostate cancer.

Authors:  Ersin Konyalioglu; Huseyin Tarhan; Ozgur Cakmak; Emel Ebru Pala; Ferruh Zorlu
Journal:  Int Braz J Urol       Date:  2015 May-Jun       Impact factor: 1.541

5.  Predictive criteria of insignificant prostate cancer: what is the correspondence of linear extent to percentage of cancer in a single core?

Authors:  Athanase Billis; Maisa M Q Quintal; Leandro L L Freitas; Larissa B E Costa; Ubirajara Ferreira
Journal:  Int Braz J Urol       Date:  2015 Mar-Apr       Impact factor: 1.541

6.  Automated Gleason Scoring and Tumor Quantification in Prostate Core Needle Biopsy Images Using Deep Neural Networks and Its Comparison with Pathologist-Based Assessment.

Authors:  Han Suk Ryu; Min-Sun Jin; Jeong Hwan Park; Sanghun Lee; Joonyoung Cho; Sangjun Oh; Tae-Yeong Kwak; Junwoo Isaac Woo; Yechan Mun; Sun Woo Kim; Soohyun Hwang; Su-Jin Shin; Hyeyoon Chang
Journal:  Cancers (Basel)       Date:  2019-11-25       Impact factor: 6.639

7.  Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade.

Authors:  Gianluigi Zanetti; Renata Zelic; Francesca Giunchi; Jonna Fridfeldt; Jessica Carlsson; Sabina Davidsson; Luca Lianas; Cecilia Mascia; Daniela Zugna; Luca Molinaro; Per Henrik Vincent; Ove Andrén; Lorenzo Richiardi; Olof Akre; Michelangelo Fiorentino; Andreas Pettersson
Journal:  Clin Epidemiol       Date:  2022-01-18       Impact factor: 4.790

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.